Director, Product Management, Oncology, Molecular Residual Disease (MRD)

Labcorp•Durham, NC

7d•$170,000 - $190,000•Hybrid

About The Position

Labcorp is seeking a Director, Product Management, Oncology, Molecular Residual Disease (MRD), to join our Oncology Product Team. Labcorp is a global leader in diagnostic testing and drug development solutions, helping healthcare providers, researchers, and patients make informed decisions that advance care. Join us in our mission to improve health and improve lives. About the Role As a global leader in diagnostic services, Labcorp is committed to improving health and improving lives. Diagnostic Marketing plays a central role as a commercial partner, driving access to innovative testing solutions, strengthening leadership in specialized diagnostics, advancing digital capabilities, and enhancing customer experience to support sustainable growth. Within this function, the Director of Product Management is responsible for portfolio strategy, commercialization, and lifecycle execution to ensure strong product performance and successful launches. The role aligns cross-functional stakeholders and represents the commercial perspective across R&D, Operations, and Market Access. It also leads forecasting, resource planning, and operational efficiency, translating market insights into strategic decisions that expand margins, improve competitiveness, and drive profitable growth. The Director, Oncology (MRD) leads the strategy and lifecycle management of Labcorp’s molecular residual disease (MRD) portfolio. This includes advancing differentiated solutions that enable treatment monitoring, early detection of recurrence, and ongoing cancer management across solid tumors and hematologic malignancies. This role translates evolving clinical evidence, emerging technologies (including tumor-informed and tumor-naïve approaches), payer dynamics, and competitive trends into actionable strategies that drive adoption and access. Working cross-functionally with Science, Medical Affairs, Product Marketing, Commercial Strategy, Market Access, IT, and Operations, the Director ensures seamless, best-in-class customer experience from test ordering through reporting. The position also requires close collaboration with oncologists, pathologists, translational researchers, and MRD thought leaders, as well as engagement with biopharma partners to support therapy-specific applications and clinical trial integration.

Requirements

Bachelor’s degree in Molecular Biology, Life Sciences or Bioengineering.
7 or more years experience in product management or portfolio strategy.
7 or more years experience in diagnostics, pharmaceuticals, or life sciences.
5 or more years managing diagnostic services or oncology testing products.
Experience with diagnostics commercialization and regulatory pathways.
Experience with market access/payor policies for diagnostics.
Forecasting and pricing experience.
Demonstrated success launching and scaling regulated diagnostic products.
Strategic thinking
Cross functional leadership
Product lifecycle management & commercialization
Scientific and clinical fluency
Analytical and forecasting capability
Stakeholder influence
Operational and financial acumen
Competitive insight
Strong product strategy and lifecycle management capability
Deep understanding of oncology clinical workflows and treatment paradigms
Technical fluency in ctDNA, NGS technologies, and assay performance tradeoffs
Knowledge of U.S. diagnostic reimbursement and access pathways
Strong analytical, financial modeling, and storytelling skills
Proven ability to lead cross functional teams without direct authority
Comfort engaging external oncologists, pathologists, and scientific leaders
Ability to operate in areas of clinical and regulatory uncertainty

Nice To Haves

3 or more years experience in circulating tumor DNA (ctDNA), NGS, or oncology diagnostics.
2 or more years experience with MRD, liquid biopsy, or longitudinal testing.
Advanced degree in Molecular Biology, Oncology or Life Sciences.
Master’s degree in Business Administration (MBA).

Responsibilities

Lead portfolio strategy and lifecycle management, including roadmap development, forecasting, and performance optimization from concept through commercialization and scale.
Apply deep disease expertise, regulatory insight, and business acumen to drive adoption, profitability, and sustained portfolio growth.
Monitor scientific, regulatory, and competitive trends to inform strategic direction and investment priorities.
Develop robust business cases encompassing market opportunity, segmentation, financial projections, operating models, and product requirements.
Serve as the commercial lead across R&D, Operations, and Market Access, ensuring alignment on product strategy, pricing, and go-to-market approach.
Represent the voice of the customer in governance and planning forums, incorporating insights into prioritization and product evolution.
Drive strategic partnerships that enhance product capabilities, expand access, and create new revenue opportunities.
Partner with Product and Customer Marketing to support differentiation, positioning, and thought leadership.
Ensure operational readiness for launches, enhancements, and acquisitions, including workflow design and execution.
Analyze utilization, access, and performance metrics to continuously improve product outcomes and inform leadership decisions.
Collaborate with Commercial, Medical Affairs, and Scientific teams on field enablement, evidence generation, and customer engagement.
Own portfolio KPIs and provide ongoing insights on growth, expansion, and optimization opportunities.
Define and execute the MRD portfolio strategy and roadmap across clinical use cases, technology platforms, and market evolution.
Translate emerging clinical evidence, clinical trials, and guideline updates into actionable product strategies.
Establish MRD use cases spanning treatment monitoring, recurrence detection, adjuvant decision-making, and clinical trial integration.
Partner with Operations to design scalable workflows that optimize performance, turnaround time and deliver a seamless ordering-to-reporting experience.
Collaborate with Market Access to develop reimbursement strategies and expand coverage for emerging indications.
Work with Medical Affairs and Science to shape evidence generation and publication strategies supporting clinical adoption and payer access.
Engage biopharma team to support external studies and trial-based applications.
Define and track key metrics such as adoption by line of therapy, longitudinal utilization, turnaround time, and payer coverage.
Build and maintain strong relationships with key opinion leaders, academic institutions, and oncology networks.